186 related articles for article (PubMed ID: 27306214)
1. Synergistic increase in efficacy of a combination of 2-deoxy-D-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis.
Jalota A; Kumar M; Das BC; Yadav AK; Chosdol K; Sinha S
Tumour Biol; 2016 Sep; 37(9):12347-12358. PubMed ID: 27306214
[TBL] [Abstract][Full Text] [Related]
2. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
Liu Y; Chen X; Luo Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine.
Xie X; Tang B; Zhou J; Gao Q; Zhang P
Oncol Rep; 2013 Aug; 30(2):773-82. PubMed ID: 23743572
[TBL] [Abstract][Full Text] [Related]
4. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
[TBL] [Abstract][Full Text] [Related]
5. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
6. 2-Deoxy-D-glucose has distinct and cell line-specific effects on the survival of different cancer cells upon antitumor drug treatment.
Maximchik P; Abdrakhmanov A; Inozemtseva E; Tyurin-Kuzmin PA; Zhivotovsky B; Gogvadze V
FEBS J; 2018 Dec; 285(24):4590-4601. PubMed ID: 30375744
[TBL] [Abstract][Full Text] [Related]
7. Suppression of chloride channel 3 expression facilitates sensitivity of human glioma U251 cells to cisplatin through concomitant inhibition of Akt and autophagy.
Su J; Xu Y; Zhou L; Yu HM; Kang JS; Liu N; Quan CS; Sun LK
Anat Rec (Hoboken); 2013 Apr; 296(4):595-603. PubMed ID: 23408563
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxy-d-Glucose Sensitizes Human Ovarian Cancer Cells to Cisplatin by Increasing ER Stress and Decreasing ATP Stores in Acidic Vesicles.
Zhang L; Su J; Xie Q; Zeng L; Wang Y; Yi D; Yu Y; Liu S; Li S; Xu Y
J Biochem Mol Toxicol; 2015 Dec; 29(12):572-8. PubMed ID: 26241884
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the glycolysis inhibitor 2-deoxy-D-glucose on the activity of pro-apoptotic agents in metastatic melanoma cells, and induction of a cytoprotective autophagic response.
Giammarioli AM; Gambardella L; Barbati C; Pietraforte D; Tinari A; Alberton M; Gnessi L; Griffin RJ; Minetti M; Malorni W
Int J Cancer; 2012 Aug; 131(4):E337-47. PubMed ID: 21913183
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma.
Pistollato F; Abbadi S; Rampazzo E; Viola G; Della Puppa A; Cavallini L; Frasson C; Persano L; Panchision DM; Basso G
Biochem Pharmacol; 2010 Nov; 80(10):1517-27. PubMed ID: 20705058
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
12. A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells.
Jalota A; Kumar M; Das BC; Yadav AK; Chosdol K; Sinha S
Oncotarget; 2018 Apr; 9(26):18351-18366. PubMed ID: 29719610
[TBL] [Abstract][Full Text] [Related]
13. Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
Pang YY; Wang T; Chen FY; Wu YL; Shao X; Xiao F; Huang HH; Zhong H; Zhong JH
Leuk Lymphoma; 2015 Jun; 56(6):1821-30. PubMed ID: 25219592
[TBL] [Abstract][Full Text] [Related]
14. Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma.
Claerhout S; Verschooten L; Van Kelst S; De Vos R; Proby C; Agostinis P; Garmyn M
Int J Cancer; 2010 Dec; 127(12):2790-803. PubMed ID: 21351258
[TBL] [Abstract][Full Text] [Related]
15. Quercetin and Sodium Butyrate Synergistically Increase Apoptosis in Rat C6 and Human T98G Glioblastoma Cells Through Inhibition of Autophagy.
Taylor MA; Khathayer F; Ray SK
Neurochem Res; 2019 Jul; 44(7):1715-1725. PubMed ID: 31011879
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.
Wu HM; Jiang ZF; Ding PS; Shao LJ; Liu RY
Sci Rep; 2015 Jul; 5():12291. PubMed ID: 26201611
[TBL] [Abstract][Full Text] [Related]
17. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
18. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells.
Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA
Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress could induce autophagy and apoptosis and enhance chemotherapy sensitivity in human esophageal cancer EC9706 cells by mediating PI3K/Akt/mTOR signaling pathway.
Zhou F; Li YH; Wang JJ; Pan J; Lu H
Tumour Biol; 2017 Jun; 39(6):1010428317705748. PubMed ID: 28631572
[TBL] [Abstract][Full Text] [Related]
20. The tocotrienol-rich fraction from rice bran enhances cisplatin-induced cytotoxicity in human mesothelioma H28 cells.
Nakashima K; Virgona N; Miyazawa M; Watanabe T; Yano T
Phytother Res; 2010 Sep; 24(9):1317-21. PubMed ID: 20127663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
